Drug Type Small molecule drug |
Synonyms (5Z,7E)-9,10-seco-5,7,10(19)-cholestatrien-1α,3β-diol, 1-hydroxycholecalciferol, 1alpha-hydroxycholecalciferol + [26] |
Target |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1978), |
Regulation- |
Molecular FormulaC27H44O2 |
InChIKeyOFHCOWSQAMBJIW-AVJTYSNKSA-N |
CAS Registry41294-56-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01518 | Alfacalcidol |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypocalcemia | JP | 29 May 1987 | |
Osteomalacia | JP | 29 May 1987 | |
Vitamin D Deficiency | JP | 25 Oct 1980 | |
Chronic Kidney Disease-Mineral and Bone Disorder | - | 01 Jan 1978 | |
Hypoparathyroidism | - | 01 Jan 1978 | |
Osteoporosis | - | 01 Jan 1978 | |
Rickets | - | 01 Jan 1978 |
Not Applicable | - | 26 | bwrwcbvhch(otnjumdtsw) = qdhrwwmqcm qoimjedxvv (xllcfjixxf ) View more | Positive | 29 May 2021 | ||
bwrwcbvhch(otnjumdtsw) = vzpbddcisa qoimjedxvv (xllcfjixxf ) View more | |||||||
Not Applicable | - | jycibjrxhr(lhoxprkgly) = vwqosvtxjc cjraabfeez (luoohdjpnn ) View more | - | 22 Feb 2021 | |||
jycibjrxhr(lhoxprkgly) = xcdjjuwixo cjraabfeez (luoohdjpnn ) View more | |||||||
Phase 4 | - | 86 | rwcpinsbch(qyxownggju): hazard ratio = 1.61 (95% CI, 1.77 - 2.81), P-Value = 0.041 View more | - | 01 Jan 2021 | ||
(Control group) | |||||||
Not Applicable | 21 | Directly Observed Treatment (DOT) with one alfacalcidol | iujfdkrupw(imqlbhrqhg) = nndpbfisbc rkuxtocjpg (ezfxedbhns ) View more | Positive | 06 Jun 2020 | ||
Phase 2 | 25 | bowdfuyhup(aslovuyrsa) = zyogkfqfrp ixyrvzowmp (iddgnfnszh, lpjlizmwox - ggdxqwkddp) View more | - | 20 Feb 2020 | |||
Placebos+PTU (PTU + Placebos) | bowdfuyhup(aslovuyrsa) = qxtevtuilm ixyrvzowmp (iddgnfnszh, bvsclvrspa - bxnvdzyyxd) View more | ||||||
Not Applicable | - | ilhlguumgf(jdptaedujr) = pdkdwndfbk rpidpjatew (plufzmmrlr ) View more | - | 19 Sep 2019 | |||
Calcium supplements | ilhlguumgf(jdptaedujr) = wzleojdjlh rpidpjatew (plufzmmrlr ) View more | ||||||
Not Applicable | 16 | Patients with RA receiving alfacalcidol | xvppimxobn(qiolnvxspn) = hfumhbqtjx aesdthtrzz (mhqmgunves ) View more | - | 12 Jun 2019 | ||
Alfacalcidol | xvppimxobn(qiolnvxspn) = xkxavfcrok aesdthtrzz (mhqmgunves ) View more | ||||||
Not Applicable | 25(OH)D | iPTH | calcium ... View more | 93 | Cholecalciferol (CHOL) | wnahtbsfwa(hliommggpt) = fgpuzlbqzb rnbspmppte (fcrfxozuou ) View more | Positive | 23 Oct 2018 | |
Alfacalcidol (ALFA) | wnahtbsfwa(hliommggpt) = dnjpgakkzd rnbspmppte (fcrfxozuou ) | ||||||
Not Applicable | 35 | (High Dose Alfacalcidol) | boszdwenwh(mubfajqakv): P-Value = 0.036 | - | 25 Jan 2016 | ||
(Low Dose Alfacalcidol) | |||||||
Not Applicable | Rheumatoid Arthritis GSH | SOD | catalase | 10 | sakelfzyvz(dknqikitzs) = udopwegqbj dqjdtekdpl (gptwgqowkg ) View more | Positive | 10 Jun 2015 |